SHORT REPORT

Familial tumoral calcinosis and testicular microlithiasis associated with a new mutation of GALNT3 in a white family

M F Campagnoli^1,*, A Pucci^2,*, E Garelli¹, A Carando¹, C Defilippi³, R Lala⁴, G Ingrosso⁵, I Dianzani⁶, M Forni² and U Ramenghi¹

¹ Paediatric Department, University of Turin, Turin, Italy
² Division of Pathological Anatomy, Department of Clinical Pathology, Paediatric Hospital Regina Margherita, Turin
³ Radiology Department, Paediatric Hospital Regina Margherita
⁴ Endocrinology Unit, Paediatric Hospital Regina Margherita
⁵ Orthopaedic Unit, Paediatric Hospital Regina Margherita
⁶ Department of Medical Sciences, University of Eastern Piedmont, Novara, Italy

Correspondence to:
Correspondence to:
Professor Ugo Ramenghi
Haematology Unit, Paediatric Department, University of Turin, Piazza Polonia 94, Torino 10126, Italy; ugo.ramenghi{at}unito.it

Background: Familial tumoral calcinosis (FTC) is a rare autosomal recessive disease characterised by the development of multiple calcified masses in periarticular soft tissues; GALNT3 gene mutations have recently been described in an African American and in a Druse Arab family with FTC.

Objective: To report the clinical and histological features caused by a new GALNT3 mutation in a white family.

Results: Homozygosity for the nonsense mutation Lys463X was found in both affected siblings, who displayed a classic phenotype, the male also having testicular microlithiasis. He is the first subject described with testicular microlithiasis in FTC.

Conclusions: The high testicular expression of GALNT3 suggests that the gene alteration could act locally by causing deposition of calcium, and the testis may be an underestimated site of calcification in FTC. Autoimmune diseases are present in several members of the family. Although immune disorders have been described in FTC, autoimmunity does not segregate with the GALNT3 mutation in this family.

Abbreviations: FTC, familial tumoral calcinosis; ITP, immune thrombocytopenic purpura; TM, testicular microlithiasis

Keywords: tumoral calcinosis; tumoral calcinosis with hyperphosphataemia; testicular microlithiasis; GALNT3

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Ichikawa, S., Sorenson, A. H., Austin, A. M., Mackenzie, D. S., Fritz, T. A., Moh, A., Hui, S. L., Econs, M. J. (2009). Ablation of the Galnt3 Gene Leads to Low-Circulating Intact Fibroblast Growth Factor 23 (Fgf23) Concentrations and Hyperphosphatemia Despite Increased Fgf23 Expression. Endocrinology 150: 2543-2550 [Abstract] [Full Text]  
• Garringer, H. J., Malekpour, M., Esteghamat, F., Mortazavi, S. M. J., Davis, S. I., Farrow, E. G., Yu, X., Arking, D. E., Dietz, H. C., White, K. E. (2008). Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis. Am. J. Physiol. Endocrinol. Metab. 295: E929-E937 [Abstract] [Full Text]  
• Liu, S., Quarles, L. D. (2007). How Fibroblast Growth Factor 23 Works. J. Am. Soc. Nephrol. 18: 1637-1647 [Abstract] [Full Text]  
• Ichikawa, S., Imel, E. A., Sorenson, A. H., Severe, R., Knudson, P., Harris, G. J., Shaker, J. L., Econs, M. J. (2006). Tumoral Calcinosis Presenting with Eyelid Calcifications due to Novel Missense Mutations in the Glycosyl Transferase Domain of the GALNT3 Gene. J. Clin. Endocrinol. Metab. 91: 4472-4475 [Abstract] [Full Text]  
• Garringer, H. J., Fisher, C., Larsson, T. E., Davis, S. I., Koller, D. L., Cullen, M. J., Draman, M. S., Conlon, N., Jain, A., Fedarko, N. S., Dasgupta, B., White, K. E. (2006). The Role of Mutant UDP-N-Acetyl-{alpha}-D-Galactosamine-Polypeptide N-Acetylgalactosaminyltransferase 3 in Regulating Serum Intact Fibroblast Growth Factor 23 and Matrix Extracellular Phosphoglycoprotein in Heritable Tumoral Calcinosis. J. Clin. Endocrinol. Metab. 91: 4037-4042 [Abstract] [Full Text]  
• Kato, K., Jeanneau, C., Tarp, M. A., Benet-Pages, A., Lorenz-Depiereux, B., Bennett, E. P., Mandel, U., Strom, T. M., Clausen, H. (2006). Polypeptide GalNAc-transferase T3 and Familial Tumoral Calcinosis: SECRETION OF FIBROBLAST GROWTH FACTOR 23 REQUIRES O-GLYCOSYLATION. J. Biol. Chem. 281: 18370-18377 [Abstract] [Full Text]